|
In This Issue:
Review Article - Kinases in Cancer
Featured Article - BH3 Domains in Apoptosis
Product Update - New Products for Your Research
Customer Corner - Request Our Catalog
Tech Corner - SDS-PAGE vs. pI, Citations, SUMOplot and Web Links
Company Info - Nature Top Supplier, Distributors, Soccer Game
Upcoming Meetings - EB 2005 in San Diego, AACR 2005 in Anaheim
 |
| Kinases in Cancer |
Review Article - The kinase protein family is one of the largest drug target families in the human genome. Recent successful launches of drugs with kinase inhibition as the mode of action
demonstrate the effectiveness of this approach. The latest reports of cancer treatment using kinase inhibitors are reviewed in this article.
Read Full Article |

| PKC Antibodies Specific for Isoform nu -
Abgent has collaborated with researchers at the UCLA School of Medicine to study the application properties for antibodies made against the different isoforms of PKC kinases.
Products Cat.# AP7025a and
AP7025b are directed against the PKC nu isoform, also called PKD3.
Products Cat.# AP7730a and
AP7730b are directed against the PKD-C2 isoform, also called PKD2. Review Data
|

|
The Cancer Kinome - The Cancer Kinome is a phylogenetic tree created by Abgent Bioinformatics staff to illustrate the role of kinases in cancer.More
|

|
|
 |
| BH3 Domains in Apoptosis
|
Featured Article - Intrafamilial and interfamilial Bcl-2 protein contacts regulate key aspects of apoptosis.
Corruption of apoptotic instructions is associated with a large subset of human diseases. Understanding regulation of apoptosis is critical to a strategy for pharmaceutical intervention. This article reviews the BH3 domain and its key role in the regulatory function of Bcl-2 family members.
Read Full Article
|

|
Bcl-2 Antibody Binding is Conformation Dependent - Abgent has collaborated with researchers at The Burnham Institute in La Jolla, CA to investigate the mechanism by which Nur77 targets mitochondria and induces apoptosis. The study utilized Abgent's antibody to the BH3 domain of the Bcl-2 protein (Cat.# AP1303a).Review Data
|

|
BH3 in Apoptosis - The BH3 in Apoptosis poster charts interactions of apoptotic proteins via BH3 domains surrounding mitochondria. Request a full size poster of the BH3 in Apoptosis for your lab. |
|
|
| |
Product Update
|
New Products
Hot Products |
|
|
| Check out our product lines for protein modification research:
|
|
| Newsletter Sign-Up |
To continue receiving
The Translation Post Subscribe Here
|
|
| Tech Corner |
Q: Why does my protein migrate by SDS-PAGE at an apparent MW different from the calculated MW?
A: Check the
pI of your protein. Very low or high pI proteins do not bind as well to SDS, and therefore the migration rate is influenced by charge and potential secondary structure in addition to MW. Post-translational modifications such as
glycosylation, sumoylation, and hyperphosphorylation can also alter migration rate. Product Application: Check out our latest product citations.
Tip: Can't find an antibody in the Abgent catalog for your target of interest? Check out our Name Resolver index on page 281 for a crossindexed list of other names used in the literature.
Bioinformatic Tools: Use SUMOplot to predict sumoylation sites in your protein sequence.
Helpful Web Links: Visit web sites with proteomics analysis tools, protein databases, or for the latest info on pharmaceutical targets in clinical trials. Here |
|
| Upcoming Meetings |
Meet Abgent staff and worldwide representatives at the following conferences:-
Apr 3-5 Experimental Biology, San Diego, CA at Booth #736
- Apr 17-20 AACR, Anaheim, CA at Booth #1741
-
Worldwide Meetings
|
|
Abgent, Inc. 10239 Flanders Court, San Diego, CA 92121 1.888.SEL.PABS
858-622-0099 858-622-0609 fax Email: info@abgent.com
|
|